tegafur has been researched along with Carcinoma, Renal Cell in 56 studies
Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The safety of prolonged administration of UFT in which tegafur and uracil were mixed in a ratio of 1:4 in molar fraction was studied in 44 cases of bladder cancer and 10 cases of renal cell carcinoma." | 7.67 | [Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma]. ( Fujioka, Y; Hirasawa, S; Ishii, Y; Ito, H; Lin, TT; Nakagami, Y; Ogawa, H; Tanaka, K; Tannawa, K; Yamada, N, 1987) |
| " Using a murine dorsal air sac (DAS) assay, we have previously shown that UFT and its metabolites, gamma-hydroxybutyric acid (GHB) and 5-fluorouracil (5-FU), inhibited the angiogenesis induced by murine renal cell carcinoma." | 3.71 | gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor. ( Aoyagi, K; Basaki, Y; Chikahisa, L; Hashimoto, A; Miyadera, K; Okabe, S; Wierzba, K; Yamada, Y; Yonekura, K, 2001) |
| "The safety of prolonged administration of UFT in which tegafur and uracil were mixed in a ratio of 1:4 in molar fraction was studied in 44 cases of bladder cancer and 10 cases of renal cell carcinoma." | 3.67 | [Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma]. ( Fujioka, Y; Hirasawa, S; Ishii, Y; Ito, H; Lin, TT; Nakagami, Y; Ogawa, H; Tanaka, K; Tannawa, K; Yamada, N, 1987) |
| " We aimed to assess the safety, tolerance, pharmacokinetics and clinical activity of S-1 combined with sorafenib in patients with mRCC." | 2.80 | Phase I/II study of S-1 in combination with sorafenib for metastatic renal cell carcinoma. ( Akaza, H; Eto, M; Fujisawa, M; Hashine, K; Naito, S; Ozono, S; Sakai, H; Shinohara, N; Tomita, Y, 2015) |
| "Patients with renal cell carcinoma were eligible if they had had at least one regimen of cytokine for metastatic disease." | 2.79 | Final results of a phase II study of S-1 in patients with cytokine-refractory metastatic renal cell carcinoma. ( Akaza, H; Fujisawa, M; Hashine, K; Mizokami, A; Naito, S; Nakagawa, M; Nishikido, M; Shinohara, N; Tatsugami, K; Tomita, Y; Tsukamoto, T, 2014) |
| "Patients continued treatment until disease progression, unacceptable toxicity, or withdrawal of consent." | 2.75 | An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma. ( Akaza, H; Fujimoto, H; Naito, S; Tsukamoto, T; Usami, M, 2010) |
| "Six patients with advanced renal cell carcinoma was treated with a new chemo-endocrine regimen consisting of Tegafur, Adriamycin, Methotrexate and Tamoxifen." | 2.67 | [A combined chemo-endocrine therapy with tegafur, adriamycin, methotrexate and tamoxifen for advanced renal cell carcinoma]. ( Abe, T; Aizawa, M; Morikawa, E; Takagi, H; Wada, A; Wada, T; Yasutomi, M, 1990) |
| "In urinary bladder cancer, the combination chemotherapy with 5-FU and low-dose CDDP has been used as a radiosensitizer." | 2.40 | [Combination chemotherapy with 5-FU and low-dose CDDP for urogenital tumors]. ( Fujinami, K; Kubota, Y, 1999) |
| "Laboratory data showed marked leukocytosis with increased serum and urinary G-CSF." | 1.37 | Combination therapy with sorafenib and S-1 for renal cell carcinoma producing granulocyte colony-stimulating factor. ( Baba, S; Kinoshita, M; Kurita, Y; Kyono, Y; Mugiya, S; Ozono, S; Takayama, T, 2011) |
| "The pathological diagnosis was renal cell carcinoma, clear cell type, grade 1, pT3bNxMx stage III." | 1.36 | [Tegafur-uracil markedly reduced pulmonary metastasis from renal cell carcinoma refractory to sorafenib, interferon and interleukin 2]. ( Homma, Y; Kaneko, T; Matsushima, H; Morimoto, H; Tsuzaka, Y, 2010) |
| "A 73-year-old man with renal cell carcinoma involving the left renal vein was treated with the embolization of the left renal artery followed by interferon-alpha and UFT." | 1.30 | [Tumor reduction in advanced renal cell carcinoma with tumor thrombus by renal embolization, interferon-alpha and UFT. A case report]. ( Hamaguchi, K; Kamura, K; Matsushita, K; Seto, K; Shiomi, K; Yamauchi, T, 1997) |
| "A 60-year-old man with renal cell carcinoma and metastases to the right 7th rib and L2 vertebra (T2N0M1, OSS) was treated with interferon-alpha and the uracil and tegafur combination following nephrectomy." | 1.29 | A case of posttherapeutic sclerotic change of bone metastasis from renal cell carcinoma which proved histopathologically to be complete response. ( Maehara, Y; Satoh, J; Shibata, Y; Shimizu, TS; Sugihara, S; Uchida, T, 1994) |
| "We report a case of renal cell carcinoma in a 76-year-old man with pulmonary metastasis and tumor thrombus in inferior vena cava." | 1.29 | [Successful management for advanced renal cell carcinoma under combination therapy with human lymphoblastoid interferon-alpha and UFT (mixture of tegafur and uracil): a case report]. ( Kanno, H; Kitami, K; Nagashima, Y; Senga, Y; Takahashi, T, 1993) |
| "This is a rare case of renal cell carcinoma with local recurrence and lung metastasis successfully treated with UFT." | 1.28 | [A case of renal cell carcinoma with lung metastasis and local recurrence effectively treated with nephrectomy and UFT]. ( Matsuda, M; Taguchi, H; Takaoka, K, 1992) |
| "He was diagnosed as having right renal cell carcinoma which had metastasized to the lung." | 1.28 | [A case of recurrence of a metastatic brain tumor which disappeared due to chemotherapy only]. ( Kayama, T; Ogawa, A; Sakurai, Y; Sato, K; Wada, T, 1990) |
| "Eighty patients of renal cell carcinoma were treated during the period." | 1.28 | [Therapy on pulmonary metastasis of renal cell carcinoma]. ( Akimoto, M; Hara, M; Hasegawa, J; Kawamura, N, 1990) |
| "The authors have monitored a case of renal cell carcinoma metastatic to the supraclavicular cavity over a twenty-year period following surgical removal of a cancerous kidney." | 1.27 | [A case report of successful immunochemotherapy of metastatic renal cell carcinoma using UFT and PSK]. ( Hongo, H; Ishizu, K; Kondo, N; Kurata, S; Kuroda, Y; Misumi, K; Nakayasu, K; Ohfuji, K; Shinagawa, H, 1987) |
| "A case of multiple lung metastasis of renal cell carcinoma in which complete remission was obtained with administration of UFT (Tegafur + Uracil) is reported." | 1.27 | [Complete remission of lung metastasis of renal cell carcinoma by (UFT) therapy]. ( Fukushima, S; Sakuramoto, T; Sugawara, T, 1987) |
| "A rare case of metastatic renal cell carcinoma which represented complete remission by chemotherapy and surgical treatment is presented." | 1.27 | [Complete remission of advanced renal cell carcinoma by chemotherapy and surgical treatment: a case report]. ( Fukuoka, H; Goto, A; Kitamura, H; Murai, T, 1987) |
| " Moreover, intratumoral concentration of 5-FU differed markedly even with the same administration method and dosage level." | 1.27 | [Anti-tumour effect of UFT on human renal cell carcinoma heterotransplanted into nude mice]. ( Furuta, M; Iizuka, N; Kondo, I; Machida, T; Masuda, F; Mori, Y; Nakada, J; Onishi, T; Suzuki, M, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (32.14) | 18.7374 |
| 1990's | 24 (42.86) | 18.2507 |
| 2000's | 6 (10.71) | 29.6817 |
| 2010's | 8 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Naito, S | 6 |
| Tatsugami, K | 2 |
| Shinohara, N | 3 |
| Tomita, Y | 3 |
| Mizokami, A | 1 |
| Fujisawa, M | 3 |
| Hashine, K | 3 |
| Nishikido, M | 2 |
| Nakagawa, M | 1 |
| Tsukamoto, T | 3 |
| Akaza, H | 8 |
| Sakai, H | 1 |
| Eto, M | 3 |
| Ozono, S | 2 |
| Kobayashi, M | 3 |
| Ikeda, H | 1 |
| Nukui, A | 2 |
| Suzuki, K | 2 |
| Sugaya, Y | 2 |
| Yuzawa, M | 1 |
| Morita, T | 2 |
| Usami, M | 2 |
| Fujimoto, H | 1 |
| Kyono, Y | 1 |
| Takayama, T | 1 |
| Kinoshita, M | 1 |
| Kurita, Y | 1 |
| Mugiya, S | 1 |
| Baba, S | 1 |
| Morimoto, H | 1 |
| Tsuzaka, Y | 1 |
| Kaneko, T | 1 |
| Matsushima, H | 1 |
| Homma, Y | 2 |
| Namiki, M | 2 |
| Vogelzang, NJ | 1 |
| Takeuchi, A | 1 |
| Shiota, M | 1 |
| Yokomizo, A | 1 |
| Inokuchi, J | 1 |
| Kuroiwa, K | 1 |
| Kiyoshima, K | 1 |
| Mitsuhata, N | 1 |
| Ito, S | 1 |
| Watanabe, Y | 2 |
| Hoshi, K | 1 |
| Kanbara, T | 1 |
| Kawasaki, Y | 1 |
| Ikeda, Y | 1 |
| Namima, T | 1 |
| Ohnuma, T | 1 |
| Satomi, Y | 1 |
| Senga, Y | 2 |
| Fukuda, M | 1 |
| Nakahashi, M | 1 |
| Ohshima, H | 1 |
| Furuhata, A | 1 |
| Yamada, Y | 6 |
| Fukatsu, H | 2 |
| Honda, N | 2 |
| Miyagawa, Y | 1 |
| Segawa, A | 2 |
| Shimizu, TS | 1 |
| Uchida, T | 1 |
| Shibata, Y | 1 |
| Satoh, J | 1 |
| Sugihara, S | 1 |
| Maehara, Y | 1 |
| Esteban, E | 1 |
| Buesa, JM | 1 |
| Cueva, J | 1 |
| Fernández, Y | 1 |
| Peláez, I | 1 |
| Fernández, JL | 1 |
| Sanz, A | 1 |
| Palacio, I | 1 |
| Estrada, E | 1 |
| Gracia, JM | 1 |
| Kanno, H | 1 |
| Kitami, K | 1 |
| Takahashi, T | 1 |
| Nagashima, Y | 1 |
| Terachi, T | 1 |
| Okada, Y | 1 |
| Takeuchi, H | 1 |
| Yoshida, O | 1 |
| Shiomi, K | 1 |
| Kamura, K | 1 |
| Seto, K | 1 |
| Hamaguchi, K | 1 |
| Matsushita, K | 1 |
| Yamauchi, T | 1 |
| Kumazawa, J | 1 |
| Omoto, T | 1 |
| Iguchi, A | 1 |
| Sagiyama, K | 1 |
| Osada, Y | 1 |
| Hiratsuka, Y | 1 |
| Miyagi, T | 1 |
| Fuse, H | 1 |
| Uchibayashi, T | 1 |
| Oda, M | 1 |
| Mizukami, Y | 1 |
| Yonekura, K | 4 |
| Basaki, Y | 4 |
| Chikahisa, L | 3 |
| Okabe, S | 3 |
| Hashimoto, A | 4 |
| Miyadera, K | 3 |
| Wierzba, K | 3 |
| Muraishi, O | 1 |
| Tokue, A | 1 |
| Fujinami, K | 1 |
| Kubota, Y | 1 |
| Shibata, J | 2 |
| Murakami, K | 1 |
| Fukushima, M | 1 |
| Nakatsuji, H | 1 |
| Yamashita, Y | 1 |
| Karashima, T | 1 |
| Sumiyoshi, Y | 1 |
| Aoyagi, K | 2 |
| Masuda, F | 8 |
| Nakada, J | 8 |
| Kondo, I | 5 |
| Furuta, N | 2 |
| Taguchi, H | 1 |
| Takaoka, K | 1 |
| Matsuda, M | 1 |
| Fujita, K | 1 |
| Munakata, A | 1 |
| Kameyama, S | 2 |
| Kanemura, M | 1 |
| Kitajima, K | 1 |
| Kawamura, T | 2 |
| Okada, K | 1 |
| Murahashi, I | 1 |
| Kawabe, K | 2 |
| Isurugi, K | 3 |
| Sato, K | 1 |
| Kayama, T | 1 |
| Sakurai, Y | 1 |
| Ogawa, A | 1 |
| Wada, T | 3 |
| Ueda, T | 1 |
| Muramatsu, T | 1 |
| Hirata, N | 1 |
| Senda, H | 1 |
| Hara, M | 1 |
| Kawamura, N | 1 |
| Hasegawa, J | 1 |
| Akimoto, M | 1 |
| Fujioka, T | 1 |
| Hasegawa, M | 1 |
| Ishikura, K | 1 |
| Nomura, K | 1 |
| Okamoto, T | 1 |
| Tanji, S | 1 |
| Koike, H | 1 |
| Kubo, T | 1 |
| Morikawa, E | 1 |
| Yasutomi, M | 2 |
| Takagi, H | 1 |
| Aizawa, M | 1 |
| Abe, T | 2 |
| Wada, A | 2 |
| Mori, Y | 5 |
| Imai, K | 1 |
| Yamanaka, H | 1 |
| Takahashi, H | 1 |
| Mashimo, T | 1 |
| Shimizu, N | 1 |
| Koya, J | 1 |
| Yajima, H | 1 |
| Kawashima, K | 1 |
| Kitaura, K | 1 |
| Kondo, N | 1 |
| Hongo, H | 1 |
| Nakayasu, K | 1 |
| Shinagawa, H | 1 |
| Ishizu, K | 1 |
| Misumi, K | 1 |
| Kuroda, Y | 1 |
| Kurata, S | 1 |
| Ohfuji, K | 1 |
| Suzuki, M | 5 |
| Mochizuki, A | 1 |
| Sugawara, T | 1 |
| Sakuramoto, T | 1 |
| Fukushima, S | 1 |
| Niijima, T | 2 |
| Aso, Y | 1 |
| Koiso, K | 1 |
| Yokoyama, M | 1 |
| Shoji, F | 1 |
| Matsuyama, H | 1 |
| Yamamoto, N | 1 |
| Sakatoku, J | 1 |
| Hara, Y | 1 |
| Sacho, T | 1 |
| Yasui, H | 1 |
| Ichikawa, T | 1 |
| Koshido, Y | 1 |
| Hayasida, S | 1 |
| Nagata, K | 1 |
| Nakagami, Y | 1 |
| Lin, TT | 1 |
| Ito, H | 1 |
| Hirasawa, S | 1 |
| Tannawa, K | 1 |
| Fujioka, Y | 1 |
| Ogawa, H | 1 |
| Tanaka, K | 1 |
| Yamada, N | 1 |
| Ishii, Y | 1 |
| Goto, A | 1 |
| Murai, T | 1 |
| Fukuoka, H | 1 |
| Kitamura, H | 1 |
| Yanase, I | 1 |
| Shirahama, T | 1 |
| Kayajima, T | 1 |
| Ohi, Y | 1 |
| Onishi, T | 2 |
| Machida, T | 4 |
| Furuta, M | 1 |
| Iizuka, N | 4 |
| Hoshino, M | 1 |
| Inoue, K | 1 |
| Higaki, M | 1 |
| Imamura, K | 1 |
| Ohnishi, T | 2 |
| Koseki, K | 1 |
| Kishi, H | 1 |
| Umeda, T | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Controlled Phase III Adjuvant Trial of High-Dose Bolus IL-2 in Patients With High-Risk Renal Cell Carcinoma[NCT00003126] | Phase 3 | 69 participants (Actual) | Interventional | 1997-06-30 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for tegafur and Carcinoma, Renal Cell
| Article | Year |
|---|---|
[The possibility of S-1 for the treatment of patients with urological cancers].
Topics: Antimetabolites, Antineoplastic; Carcinoma, Renal Cell; Clinical Trials, Phase II as Topic; Drug Adm | 2006 |
[A case of pulmonary metastasis from renal cell carcinoma with complete response to interferon-alpha and tegafur/uracil (UFT) but possibly UFT-induced liver dysfunction and leukoencephalopathy-like symptoms].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Carcinoma, Renal Cell; Chemical and | 1999 |
[Combination chemotherapy with 5-FU and low-dose CDDP for urogenital tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cisplatin; Combined Modality | 1999 |
11 trials available for tegafur and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Final results of a phase II study of S-1 in patients with cytokine-refractory metastatic renal cell carcinoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Renal Cell; Cytokines; Disease-Free Surviva | 2014 |
Phase I/II study of S-1 in combination with sorafenib for metastatic renal cell carcinoma.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal | 2015 |
An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma.
Topics: Adult; Aged; Antimetabolites, Antineoplastic; Carcinoma, Renal Cell; Cytokines; Disease Progression; | 2010 |
Multicenter phase II trial of S-1 in patients with cytokine-refractory metastatic renal cell carcinoma.
Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Renal Cell; Dihydrouracil Dehydrogenase (NADP); Di | 2010 |
[Clinical study of renal cell carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; | 1993 |
Phase II study of oral ftorafur and uracil in patients with advanced renal cell carcinoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Female; Humans; Kidney | 1993 |
Postoperative UFT adjuvant and the risk factors for recurrence in renal cell carcinoma: a long-term follow-up study. Kyushu University Urological Oncology Group.
Topics: Antimetabolites, Antineoplastic; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Drug Combinations; F | 1997 |
Adjuvant chemotherapy with vinblastine, adriamycin, and UFT for renal-cell carcinoma.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Chemotherapy, Ad | 1992 |
[Treatment of renal cell carcinoma with human lymphoblastoid interferon alpha and UFT in combination. A prospective multicenter trial].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Interferon Type I; Ki | 1991 |
[A combined chemo-endocrine therapy with tegafur, adriamycin, methotrexate and tamoxifen for advanced renal cell carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Doxorubicin; Female; Hu | 1990 |
[Combination therapy of renal cell carcinoma with interferon-alpha and UFT (or FT-207)].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modalit | 1989 |
42 other studies available for tegafur and Carcinoma, Renal Cell
| Article | Year |
|---|---|
Clinical outcome and prognostic survival factors in patients with advanced renal cell carcinoma treated with very low-dose interleukin-2, interferon-alpha, and tegafur-uracil: a single-institution experience.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Administrat | 2008 |
Combination therapy with sorafenib and S-1 for renal cell carcinoma producing granulocyte colony-stimulating factor.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Renal Cell; Drug | 2011 |
[Tegafur-uracil markedly reduced pulmonary metastasis from renal cell carcinoma refractory to sorafenib, interferon and interleukin 2].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Carcinoma, Renal Cell; Drug | 2010 |
Another step toward the cure of metastatic renal cell carcinoma?
Topics: Antineoplastic Agents; Carcinoma, Renal Cell; Clinical Trials as Topic; Drug Combinations; Humans; K | 2010 |
Sorafenib augments cytotoxic effect of S-1 in vitro and in vivo through TS suppression.
Topics: Animals; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Cell Line, Tumor; Drug Com | 2011 |
[Renal transplantation surgery is closely linked with treatment for bilateral synchronous renal cell carcinomas or renal tumors in solitary kidney].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Combinations; Fema | 2004 |
[Pulmonary and lymph node metastases of renal cell carcinoma which completely responded to oral administration of UFT--a case report].
Topics: Administration, Oral; Antineoplastic Agents; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Drug Adm | 2007 |
[Chemotherapy of renal cell carcinoma. 3. Single-agent therapy with FT-207 or vinblastine].
Topics: Adenocarcinoma; Administration, Oral; Adult; Aged; Carcinoma, Renal Cell; Female; Fluorouracil; Huma | 1984 |
A case of posttherapeutic sclerotic change of bone metastasis from renal cell carcinoma which proved histopathologically to be complete response.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Carcinoma, Renal Cell; Diagnostic Im | 1994 |
[Successful management for advanced renal cell carcinoma under combination therapy with human lymphoblastoid interferon-alpha and UFT (mixture of tegafur and uracil): a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Thera | 1993 |
[Long-term complete response of multiple lung metastases from renal cell carcinoma induced by combination therapy with interferon alpha and UFT: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Interferon-alp | 1993 |
[Tumor reduction in advanced renal cell carcinoma with tumor thrombus by renal embolization, interferon-alpha and UFT. A case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Combinations; Embo | 1997 |
[Pulmonary metastasis from renal cell carcinoma diagnosed by using thoracoscopic biopsy: a case report].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Carcinoma, Renal Cell; Female; Humans; | 1998 |
UFT and its metabolites inhibit the angiogenesis induced by murine renal cell carcinoma, as determined by a dorsal air sac assay in mice.
Topics: 4-Butyrolactone; Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cel | 1999 |
[Anti-metastatic and anti-angiogenic activity of UFT in a lung spontaneous metastasis model in mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Kidney Neoplasms; Lu | 1999 |
[Bilateral synchronous renal cell carcinoma: report of three cases].
Topics: Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Chemotherapy, Adjuvant; Female; Humans; Interfer | 1999 |
UFT and its metabolites inhibit cancer-induced angiogenesis. Via a VEGF-related pathway.
Topics: Air Sacs; Animals; Antineoplastic Combined Chemotherapy Protocols; Biological Assay; Carcinoma, Rena | 2000 |
gamma-Hydroxybutyric acid and 5-fluorouracil, metabolites of UFT, inhibit the angiogenesis induced by vascular endothelial growth factor.
Topics: Angiogenesis Inhibitors; Animals; Antimetabolites, Antineoplastic; Breast Neoplasms; Carcinoma; Carc | 2001 |
[A case of renal cell carcinoma with lung metastasis and local recurrence effectively treated with nephrectomy and UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; C | 1992 |
Concentration of 5-fluorouracil in renal cells from cancer patients administered a mixture of 1-(2-tetrahydrofuryl)-5-fluorouracil and uracil.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Fluorouracil; Humans; Kidney; | 1991 |
[Adjuvant chemotherapy with vinblastine, adriamycin and UFT (VAU) for renal cell carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Doxorubicin; Drug Admin | 1991 |
[A case of recurrence of a metastatic brain tumor which disappeared due to chemotherapy only].
Topics: Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carcinoma, Renal Cell; Humans; Kidn | 1990 |
[Various questions concerning the treatment of renal cell carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Interferon Type I; Ki | 1990 |
[Combination chemotherapy of human renal cell carcinoma in athymic nude mice with human lymphoblastoid interferon (HLBI) and UFT, 5-Fu].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Th | 1990 |
[Therapy on pulmonary metastasis of renal cell carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Thera | 1990 |
[Antitumor activity of UFT against murine renal cell carcinoma: a study on the suppression tumor metastases].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug Screening Assay | 1990 |
Efficacy of UFT for the treatment of renal cell carcinoma.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Female; Humans; Kidney | 1989 |
[A case report of successful immunochemotherapy of metastatic renal cell carcinoma using UFT and PSK].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Clavicle; Humans; Kidne | 1987 |
[Complete regression of pulmonary metastasis from renal cell carcinoma following treatment with UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Combined Modality Therapy; Hu | 1987 |
[Complete remission of lung metastasis of renal cell carcinoma by (UFT) therapy].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Kidney Neoplasms; Lun | 1987 |
[Collaborative study of UFT in far-advanced renal cell carcinoma. Urological Cooperative UFT Study Group].
Topics: Adult; Aged; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug A | 1988 |
[Clinical study of UFT in far-advanced renal cell carcinoma].
Topics: Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Female; | 1988 |
[Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Carcinoma, Trans | 1987 |
[Complete remission of advanced renal cell carcinoma by chemotherapy and surgical treatment: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cisplatin; Combined Modality | 1987 |
[Antitumor activity of UFT and interferon-alpha against human renal cell carcinoma in athymic nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Interferon T | 1988 |
[A combined chemo-endocrine therapy of advanced renal cell carcinoma].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Doxorubicin; Drug Administrat | 1987 |
[Anti-tumour effect of UFT on human renal cell carcinoma heterotransplanted into nude mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cell Division; Human | 1988 |
[Clinical effect of UFT in advanced renal cell carcinoma].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Drug | 1988 |
[Treatment of established human renal cell carcinoma--experimental treatment with interferon and UFT].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Humans; Interferon T | 1988 |
[5-FU concentration in blood and tissue of patients with renal cell carcinoma after administration of UFT].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Fluorouracil; Humans; Kidney | 1985 |
[Clinical study of UFT in renal cell carcinoma].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Capsules; Carcinoma, Ren | 1985 |
[Effects of UFT in advanced renal cell cancer].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; D | 1985 |